<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02627391</url>
  </required_header>
  <id_info>
    <org_study_id>AOM 140460</org_study_id>
    <nct_id>NCT02627391</nct_id>
  </id_info>
  <brief_title>Early Surgery for Patients With Asymptomatic Aortic Stenosis</brief_title>
  <acronym>ESTIMATE</acronym>
  <official_title>Early Surgery for Patients With Asymptomatic Aortic Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many cardiologists are convinced that early surgery in asymptomatic aortic stenosis (AS)
      saves lives. However there is currently no direct evidence for this and most recommendations
      from the ESC/ EACTS or ACC/ AHA in this field are supported by Level-B or C evidence.
      Therefore, the investigators designed a randomized controlled trial to demonstrate whether
      early surgery improves mortality and morbidity of patients with asymptomatic severe AS and
      low operative risk.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combination of overall mortality and cardiac morbidity</measure>
    <time_frame>1 year after randomization.</time_frame>
    <description>Any adverse cardiac event requiring hospitalization. Adverse cardiac events include: 1/ development of any symptom clearly related to AS (dyspnea, angina, pre-syncope or syncope during exercise); 2/ major adverse cardiac events defined as congestive heart failure or acute coronary syndrome; 3/ death of any cause, including cardiac death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Each items of the composite criteria, overall and cardiovascular mortality and cardiac morbidity</measure>
    <time_frame>1 year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with preserved LV systolic function ( LVEF &gt;50% according to echocardiography ) in each group</measure>
    <time_frame>assessed at 3 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance capacities assessed by speckle-tracking imaging (longitudinal function) in each group</measure>
    <time_frame>assessed at 3 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Exercise test (Exercise Electrocardiogram)</measure>
    <time_frame>assessed at 3 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Aortic Valve Surgery</condition>
  <arm_group>
    <arm_group_label>Early surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical aortic valve replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed surgery according to guidelines</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical aortic valve replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early surgical aortic valve replacement</intervention_name>
    <arm_group_label>Early surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Delayed Surgical aortic valve replacement</intervention_name>
    <arm_group_label>Delayed surgery according to guidelines</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Adult patient, aged between 18 and 80 years (18 ≤ age ≤80)

          -  Low operative risk, defined as EuroSCORE II ≤ 5%

          -  No symptom potentially attributable to AS: no dyspnea, angina or syncope during
             exercise

          -  No class I indication for surgery

          -  No symptom/ fall in blood pressure during exercise test

          -  Severe AS according to current echocardiography criteria: Vmax &gt; 4.0 m/s and/ or MPG &gt;
             40 mm Hg); AVA &lt; 1.0 cm2 (not mandatory)

          -  Preserved LV systolic function: LVEF &gt;50% according to echocardiography ; no LV wall
             motion abnormality

          -  Signed informed consent

        Exclusion criteria

          -  Moderate/ high operative risk for aortic valve replacement, defined as EuroSCORE II &gt;
             5%

          -  Class-I indication for AVR (ESC-EACTS 2012, ACC/ AHA 2014) or fall in blood pressure
             during exercise testing (Class-IIa)

          -  Other indication for cardiac surgery (CABG, thoracic aorta)

          -  Positive exercise test including A/ unmasking of symptoms (angina, dyspnea at low
             workload, dizziness or syncope) during exercise or B/ Fall in systolic blood pressure
             during exercise below the baseline value.

          -  Patients unable to perform the exercise ECG

          -  More than mild AR (&gt;grade 2/4)/ other significant valve disease LVEF ≤ 50%

          -  Serum creatinine &gt;160 μmol/L

          -  Serious extra cardiac comorbidity/ life expectancy &lt;2 years

          -  Patient included in another trial with signed informed consent

          -  Patient not affiliated to social insurance

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc MONIN, MD PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Luc MONIN, MD PhD.</last_name>
    <phone>(0)1 49 81 28 10</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-luc.monin@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc MONIN, MD PhD</last_name>
      <phone>(0)1 49 81 28 10</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-luc.monin@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Piérard L, Guéret P. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation. 2009 Jul 7;120(1):69-75. doi: 10.1161/CIRCULATIONAHA.108.808857. Epub 2009 Jun 22.</citation>
    <PMID>19546391</PMID>
  </reference>
  <reference>
    <citation>Farré N, Gómez M, Molina L, Cladellas M, Blé M, Roqueta C, Ascoeta MS, Comin-Colet J, Vila J, Bruguera J. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis. Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):52-7. doi: 10.1016/j.rec.2013.06.020. Epub 2013 Oct 20.</citation>
    <PMID>24774264</PMID>
  </reference>
  <reference>
    <citation>Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185. doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3. Erratum in: J Am Coll Cardiol. 2014 Jun 10;63(22):2489. Dosage error in article text.</citation>
    <PMID>24603191</PMID>
  </reference>
  <reference>
    <citation>Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012 Oct;33(19):2451-96. doi: 10.1093/eurheartj/ehs109. Epub 2012 Aug 24.</citation>
    <PMID>22922415</PMID>
  </reference>
  <reference>
    <citation>Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999 Jul 15;341(3):142-7.</citation>
    <PMID>10403851</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic valve</keyword>
  <keyword>Stenosis</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

